-
Mashup Score: 23Elranatamab treatment in a multiple myeloma patient undergoing renal dialysis | Published in Clinical Hematology International - 2 day(s) ago
By Zoé Van de Wyngaert, Irene Romera-Martinez & 6 more. Despite end-stage renal impairment, treatment with the anti-B cell maturation antigen (BCMA)xCD3 bispecific antibody proved feasible without unexpected side effects. Increased attention to infectious risk is crucial for fragile patients.
Source: chi.scholasticahq.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2IACH News of the week 12.5.24 - 2 day(s) ago
Measurable residual disease in multiple myeloma. With increasing evidence that measurable residual disease (MRD) negativity is associated with clinical outcomes, MRD is now being used as a primary endpoint in randomized phase 3 trials. Mass spectrometry (MS) can detect multiple myeloma (MM)-derived monoclonal proteins in peripheral blood (PB) with high sensitivity, potentially serving as a PB assay for MRD. A recent study evaluated the significance of PB MS MRD negativity during post-transplant therapy
Source: itnewsletter.itnewsletter.co.ilCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 49Recommendations on prevention of infections during chimeric antigen receptor T‐cell and bispecific antibody therapy in multiple myeloma - 13 day(s) ago
The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.
Source: onlinelibrary.wiley.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 25Thierry Facon - COMy 2024 Invitation - 15 day(s) ago
This is “Thierry Facon – COMy 2024 Invitation” by CME Congresses on Vimeo, the home for high quality videos and the people who love them.
Source: vimeo.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2IACH News of the Week - 15 day(s) ago
IACH News of the Week IACH News of the Week, curated by Dr Edwin Uriel Suárez , is a weekly summary of the latest advancements and discoveries in the field of hematology compiled in an easy-to-digest format. It highlights research breakthroughs, clinical trial results, interesting case studies, and important health advisories – all within the
Source: clinical-hematology.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 49
By Jana Sawyer, Taylor Elliott & 4 more. The acute toxicities that occur from conditioning chemotherapy can impact the peri-transplant period and have substantial implications on patients’ tolerability and outcomes, irrespective of the treatment of their disease.
Source: chi.scholasticahq.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 15Elena Zamagni - COMy 2024 Invitation - 21 day(s) ago
This is “Elena Zamagni – COMy 2024 Invitation” by CME Congresses on Vimeo, the home for high quality videos and the people who love them.
Source: vimeo.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 15Elena Zamagni - COMy 2024 Invitation - 21 day(s) ago
This is “Elena Zamagni – COMy 2024 Invitation” by CME Congresses on Vimeo, the home for high quality videos and the people who love them.
Source: vimeo.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 29
By Allison C. Y. Tso, Sanchalika Acharyya & 6 more. Real-world data on the outcome of Asian patients with secondary hemophagocytic lymphohistiocytosis (HLH), especially on dengue-associated HLH, are limited to small case series.
Source: chi.scholasticahq.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 12Risks and benefits of cannabis as a pain control modality in patients with sickle cell disease | Published in Clinical Hematology International - 24 day(s) ago
By Jeremy W. Jacobs, Brian D. Adkins & 3 more. Opioids have historically been, and continue to be, the mainstay for managing pain in patients with SCD.
Source: chi.scholasticahq.comCategories: General Medicine News, Hem/OncsTweet
Elranatamab treatment in a myeloma patient undergoing renal dialysis- Published in Clin Hematol Int the official journal of @TheIACH @IMFmyeloma @MyelomaTeacher @MyelomaUK @Florent_Malard @af3m_myelome https://t.co/EKa1l0Mxsz